Investor Relations

Stock price graph
     

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

PDF 2013 Annual Report [ 4.4 MB]

Recent Releases

Aug 12, 2014
FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test

Aug 7, 2014
Exact Sciences to Participate in Canaccord Genuity Growth Conference

Jul 24, 2014
Doyle, Arora elected; Sterling reelected to Exact Sciences' board of directors

View all releases »

Stock Quote

Ticker:
EXAS
Exchange:
NASDAQ
Price:
19.52
Change:
+ 1.18
Volume:
5,199,200
4:00 PM ET on Aug 20, 2014
Delayed at least 20 minutes.
Provided by eSignal.

IR Search